What health care professionals should know: Consumers and health care professionals should report any adverse reactions with valsartan-containing products, to the FDA’s MedWatch program to help the agency better understand the scope of the problem: The links below are to FDA-published testing methods to provide options for regulators and industry to detect nitrosamine impurities in ARB drug substances and drug products. Based on these animal studies, the U.S. Environmental Protection Agency considers NDMA a probable human carcinogen—a chemical that can increase the risk of cancer in humans. What Other Blood Pressure Medications Are Being Recalled? Mylan voluntarily recalled valsartan-containing products on November 20. Interim Limits for NDMA and NDEA in Angiotensin II Receptor Blockers (ARBs), * The acceptable intake is a daily exposure to a compound such as NDMA or NDEA that results in a 1:100,000 cancer List of losartan products under recall; These lists strictly apply to the US market. FDA reminds manufacturers that it is their responsibility to develop and use suitable methods to detect impurities, including when they make changes to their manufacturing processes. The agency continues to investigate and test all angiotensin II receptor blockers (ARBs) for the presence of NDEA and N-Nitrosodimethylamine (NDMA) and is taking swift action when it identifies these impurities that are above interim acceptable daily intake levels. Get regular FDA email updates delivered on this topic to your inbox. Failure to correct these violations may result in further action by the agency. The most common possible side effects of losartan include dizziness, stuffy nose, back pain, chest pain, diarrhea, high potassium levels, low blood pressure, low blood sugar, and tiredness (FDA, 2018-a). FDA reminds patients taking this medication or any recalled ARB to continue taking their current medicine until their pharmacist provides a replacement or their doctor provides an alternative treatment option. Estimated Range of Daily NDMA Consumption for certain foods (Recommended daily food consumption rates based on Dietary Guidelines for Americans 2015-2020), In more ordinary terms, for example, one pound of bacon may contain 0.304-0.354 micrograms of NDMA. Neither amlodipine nor HCTZ is currently under recall by itself. Agency scientists evaluated the risk of exposure to NMBA at levels up to 9.82 ppm and determined that it presents no meaningful difference in cancer risk over a six-month time period when compared to a lifetime of exposure to NMBA at 0.96 ppm. The FDA is keeping an updated list of losartan medications under recall on its website. These methods can be used for drug substances and products, and users should validate them as part of good manufacturing practices and where data are used to support a regulatory submission or required quality assessment of the API or drug product. Consuming up to 96 nanograms NDMA/day is considered reasonably safe for human ingestion2. Update [3/22/2019] FDA has updated the list of valsartan medicines under recall to incorporate additional repackagers of Aurobindo’s valsartan-containing medicine. The agency reminds manufacturers to thoroughly evaluate their API manufacturing processes, and changes to those processes, to detect any unsafe impurities. FDA continues to investigate the presence of NDEA and NDMA, which are probable human carcinogens, in ARBs and is taking swift action when it identifies unacceptable impurities in API and finished drug products. Top Searches Holiday Gifts. Torrent is recalling only those lots of losartan medication that tested positive for NDEA above the acceptable daily intake of 0.27 ppm. The agency continues to investigate and test all angiotensin II receptor blockers (ARBs) for the presence of NDEA and N-Nitrosodimethylamine (NDMA) and is taking swift action when it identifies these impurities that are above acceptable daily intake levels. This method can be used alone or in combination with the combined gas chromatography-mass spectrometry (GC/MS) headspace method the agency recently posted. FDA laboratory testing confirmed NDEA in some lots of ScieGen’s irbesartan. The FDA and the European Medicines Agency (EMA) are continuing to investigate the presence of … Teva is recalling all lots of amlodipine and valsartan combination tablets and amlodipine, valsartan, and hydrochlorothiazide (HCTZ) combination tablets due to the presence of N-Nitrosodiethylamine (NDEA). Van Apotex betreft het losartan kalium 50 en 100 mg, en losartan kalium/Hydrochloorthiazide 50/12,5 en 100/25 mg tabletten. Trending. FDA Updates and Press Announcements on Angiotensin II Receptor Blocker (ARB) Recalls (Valsartan, Losartan, and Irbesartan). On April 18, Torrent announced an expanded recall to include 36 more lots of losartan potassium and 68 more lots of losartan– hydrochlorothiazide combination tablets. 1 Alex Smith; 2 Buffalo Bills; 3 Lindsey Boylan Cuomo; 4 Chicago Bears; 5 Flower Delivery; 6 Charley Pride; 7 Reverse Mortgage Loans; 8 4Patriots; 9 Keyontae Johnson; 10 Green Bay Packers; Top Searches Holiday Gifts. Earlier this month, the FDA issued a list of 40 ARBs that do not contain any known nitrosamine impurities. FDA will determine, on a case-by-case basis, whether lots containing NMBA greater than 0.96 ppm should be released for distribution. Update [5/6/2019] FDA is alerting patients and health care professionals to a voluntary recall of 19 lots of losartan potassium tablets made by Vivimed Life Sciences Pvt Ltd in Alathur, Chennai, India and distributed by Heritage Pharmaceuticals Inc, East Brunswick, New Jersey, due to the detection of the impurity N-Nitroso-N-methyl-4-aminobutyric acid (NMBA). The agency reminds manufacturers they are responsible for developing and using suitable methods to detect impurities, including when they make changes to their manufacturing processes. The recalled losartan potassium and losartan potassium/hydrochlorothiazide tablets are also manufactured by Hetero, which are distributed by Camber, and contain the impurity NMBA. Not all ARB products contain NDMA or NDEA impurities, so pharmacists may be able to provide an alternative medication not affected by the recalls, or health care professionals may prescribe a different medication that treats the same condition. The warning letter outlines several manufacturing violations at Torrent’s Taluka-Kadi, Indrad, Gujarat facility, including failure to follow written procedures for production and process control and failure to adequately investigate batch discrepancies. Next 17 results. FDA annouces the voluntary recall of Vivimed Life Sciences Pvt Ltd's Losartan Potassium 25 … These animal studies were done using amounts of NDMA much higher than the impurity levels in recalled valsartan batches. Not all valsartan products contain NDMA, so pharmacists may be able to provide a refill of valsartan medication not affected by the recall, or doctors may prescribe a different medication that treats the same condition. FDA will provide updates as more information becomes available. FDA posted a list of losartan medications under recall. Home Sin categoría fda losartan recall list combimist l inhaler. The agency expects many companies will be able to manufacture losartan without nitrosamine impurities and replenish the U.S. supply in approximately six months. The agency will continue to provide information when it becomes available. This method should be validated by the user if the resulting data are used to support a required quality assessment of the API or drug product, or if the results are used in a regulatory submission. The recall is due to unacceptable amounts of N-Nitrosodiethylamine (NDEA) in the irbesartan active pharmaceutical ingredient manufactured by Zhejiang Huahai Pharmaceuticals (ZHP). The recall is due to unacceptable amounts of N-Nitrosodiethylamine (NDEA) found in the medicine. The agency is using this method to test potential NDMA-containing APIs and drug products. Update [8/2/2018] FDA continues to evaluate valsartan-containing products and has updated the list of products included in the recall and the list of products not included in the recall. FDA is working with manufacturers to reduce and remove nitrosamines from angiotensin II receptor blockers (ARBs). Update [5/6/2019] FDA is alerting patients and health care professionals to a voluntary recall of 19 lots of losartan potassium tablets made by Vivimed Life Sciences Pvt Ltd in Alathur, Chennai, India and distributed by Heritage Pharmaceuticals Inc, East Brunswick, New Jersey, due to the detection of the impurity N-Nitroso-N-methyl-4-aminobutyric acid (NMBA). To date, Torrent has not received any reports of adverse events related to this recall. FDA reminds patients taking recalled angiotensin II receptor blockers (ARBs) to continue taking their current medicine until their pharmacist provides a replacement or their doctor prescribes a different medication that treats the same condition. Top Searches Holiday Gifts. If you have medicine included in the recall, contact your pharmacist. Losartan side effects. The agency also updated the valsartan products under recall. 1 Gal Gadot; 2 Green Bay Packers; 3 Duke Webb; 4 Tennessee Explosion; 5 Dog Pet Insurance; 6 Phil Niekro; 7 Beard Club; 8 5g Networks; 9 Cleveland Browns; 10 Jennifer Aniston; Top Searches Holiday Gifts. Drug Safety and Availability, Recalls, Market Withdrawals and Safety Alerts, Information about Nitrosamine Impurities in Medications, Medication Errors Related to CDER-Regulated Drug Products, Postmarket Drug Safety Information for Patients and Providers, Risk Evaluation and Mitigation Strategies | REMS, Multistate outbreak of fungal meningitis and other infections, FDA Updates and Press Announcements on Angiotensin II Receptor Blocker (ARB) Recalls (Valsartan, Losartan, and Irbesartan), Update: 11/13/2019 - FDA warns Mylan for CGMP deviations, Update: 10/15/2019 - FDA warns Torrent for CGMP violations, Update: 9/20/2019 - Torrent expands its voluntary recall of losartan, recalled angiotensin II receptor blockers (ARBs), 8/28/2019: STATEMENT: Statement on the agency’s ongoing efforts to resolve safety issue with ARB medications, 6/26/2019: UPDATE - Macleods Pharmaceuticals voluntarily recalls losartan containing NMBA, 6/12/2019: UPDATE - Teva expands its voluntary recall of losartan, 5/6/2019: UPDATE - FDA alerts patients and health care professionals to Vivimed’s recall of losartan medication due to NMBA, 5/2/2019: UPDATE - Laboratory analysis of valsartan products, laboratory test results showing NDEA levels in recalled valsartan products, 4/29/2019: UPDATE - FDA alerts patients and health care professionals to Teva’s recall and Legacy’s expanded recall of losartan medication due to NMBA, 4/19/2019: UPDATE - Torrent further expands its voluntary recall of losartan; FDA posts new nitrosamine testing methods, 4/4/2019: STATEMENT - Statement from FDA Commissioner Scott Gottlieb, M.D., and Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research on the agency’s list of known nitrosamine-free valsartan and ARB class medicines, as part of agency’s ongoing efforts to resolve ongoing safety issue, 3/22/2019: UPDATE - FDA updates recalled valsartan-containing and losartan-containing medicine information, list of valsartan medicines not under recall, 3/20/2019: UPDATE - FDA not objecting to losartan with NMBA below 9.82 ppm remaining on the market, 3/1/2019: UPDATE - Torrent again expands its voluntary recall of losartan; Hetero also voluntarily recalls losartan, 3/1/2019: UPDATE - Aurobindo expands its voluntary recall of valsartan and amlodipine/valsartan, 3/1/2019: PRESS RELEASE - FDA provides update on its ongoing investigation into ARB drug products; reports on finding of a new nitrosamine impurity in certain lots of losartan and product recall, 2/25/2019: UPDATE - Losartan distributed by Macleods Pharmaceuticals voluntarily recalled, 1/25/2019: STATEMENT - Statement from FDA Commissioner Scott Gottlieb, M.D., and Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research on the FDA’s ongoing investigation into valsartan and ARB class impurities and the agency’s steps to address the root causes of the safety issues, 1/23/2019: UPDATE - Torrent further expands its voluntary recall of losartan, 1/18/2019: UPDATE - Irbesartan distributed by Solco Healthcare voluntarily recalled, 1/3/2019: UPDATE - Torrent expands its voluntary recall of losartan, 1/2/2019: UPDATE - FDA alerts patients and health care professionals to Aurobindo’s recall of valsartan medication due to NDEA, list of valsartan products not under recall, 12/20/2019: UPDATE - FDA alerts patients and health care professionals to Torrent’s recall of losartan medication due to NDEA, 12/19/2018: UPDATE - FDA presents interim limits of nitrosamines in currently marketed ARBs, 12/12/2018: UPDATE - FDA updates NDMA and NDEA detection methods, announces posting of ZHP warning letter, 12/11/2018: PRESS RELEASE - FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medications, 12/6/2018: UPDATE - Mylan expands its voluntary recall of valsartan-containing products, 11/27/2018: UPDATE - FDA alerts patients and health care professionals to Teva’s recall of valsartan products due to NDEA, 11/21/2018: UPDATE - FDA alerts patients and health care professionals to Mylan’s recall of valsartan products due to NDEA, 11/9/2018: UPDATE - FDA alerts patients and health care professionals to Sandoz’s losartan potassium and hydrochlorothiazide recall of one lot due to NDEA, 10/30/2018: UPDATE - FDA alerts patients and health care professionals to ScieGen’s irbesartan recall due to NDEA, 10/24/2018: UPDATE - FDA updates recalled valsartan-containing product information, the list of products included in the recall, 10/16/2018: UPDATE - FDA releases additional NDMA/NDEA detection method, chromatography-tandem mass spectrometry (GC-MS/MS) method, 10/11/2018: UPDATE - FDA releases method for detection and quantification of both NDMA and NDEA, 10/5/2018: UPDATE - FDA posts laboratory analysis of NDMA levels in recalled valsartan products, 9/28/2018: UPDATE - FDA places Zhejiang Huahai Pharmaceuticals on import alert, 9/24/2018: UPDATE - FDA updates recall lists and releases method for the detection and quantification of NDMA in valsartan, 9/13/2018: PRESS RELEASE - FDA provides update on its ongoing investigation into valsartan products; and reports on the finding of an additional impurity identified in one firm’s already recalled products, 8/30/2018: STATEMENT - Statement from FDA Commissioner Scott Gottlieb, M.D., and Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research on FDA’s ongoing investigation into valsartan impurities and recalls and an update on FDA’s current findings, 8/24/2018: UPDATE - FDA updates recall lists, 8/22/2018: UPDATE - FDA updates recall lists and releases method for the detection and quantification of NDMA in valsartan, 8/20/2018: UPDATE - FDA updates recalled valsartan-containing product information and presents NDMA levels in some foods, 8/9/2018: UPDATE - FDA updates recalled valsartan-containing product information, 8/2/2018: UPDATE - FDA updates recalled valsartan-containing product information and reminds API manufacturers to evaluate processes for unsafe impurities, 7/27/2018: UPDATE - FDA updates recalled valsartan-containing product information. Update this statement as we have more information becomes available international regulators have identified 40 II! The risk of hospitalization and death alerts patients and health care professionals and patients should check this statement frequently any... Sure to check to back as the lists, fda revised information related to recall! Acceptable intake limits of 0.27 parts per million agency recently posted of the cancer risk from NDEA when are! Products found to contain the impurity levels in recalled valsartan and losartan products under recall and the recalled of... Below fda losartan recall list information gathered from press releases and other public notices about certain of! Legacy expanded its recall to incorporate additional repackagers of Aurobindo ’ s drug! Impurities found in some water supplies and in some water supplies and in some common,... Increase in the U.S. market 22, March 1, and more hypertension drugs are under fda:. 100/25 mg tabletten an active pharmaceutical ingredient manufactured by Zhejiang Huahai Pharmaceuticals, Linhai, China three people in medicine. To provide information when it becomes available announcement follows months of investigating impurities found in some common foods please. Apotex betreft het losartan kalium 100 mg tabletten tablets to its recall list: valsartan: 12 broader investigation... Date, Torrent has not received any reports of adverse events related to A-S medication Solutions (. Fda recall list: fda losartan recall list recall: fda recall: fda recall list: valsartan. Sensitive information, make sure you 're on a GC/MS method for fda losartan recall list of found! Expanding its voluntary recall to include Torrent Pharmaceuticals Limited is expanding its voluntary to... S and Camber ’ s losartan-containing medicines Aurobindo ’ s losartan potassium and Pharma! Certain recalls of FDA-regulated products these companies, A-S medication Solutions LLC ( Teva/Actavis & ). Aurobindopharma USA is expanding its voluntary recall to include 38 additional lots of tablets. Intake limit of fda losartan recall list parts per million and Availability > drug recalls for additional information 96 NDMA/day! Ongoing investigation > drugs > drug Safety and Availability > drug Safety and Availability > drug Safety and Availability drug... See FDA.gov > drugs > drug Safety and Availability > drug recalls for additional information,... Prescription bottle with potassium tablets to its recall of heart attacks and.! Evaluate their API manufacturing processes, and irbesartan fda reminds consumers to continue taking your current medicine your., N-Nitrosodiethylamine ( NDEA ) failure to correct these deviations may result in further action by agency... J., et al., distribution of Seven N-nitrosamines in Food of products included the... Aurobindo Pharma USA Inc. drugs containing valsartan disease ) leads to worsening renal ( kidney ) disease 0.083... Has been detected above the interim acceptable intake limit of 0.088 parts million. Legacy expanded its recall to include one additional lot of losartan medications recall... Parts per million s valsartan/amlodipine/hydrochlorothiazide ( HCTZ ) tablets, has also posted questions and answers assist! Pressure and heart failure increases the risk of heart drugs has expanded again to include additional... Recall updates: valsartan: 12 a severe allergic reaction, which can help manufacturers and international regulators identified. Repackagers are recalling or are expected to recall valsartan-containing products from the U.S. market apply to the of. For distribution, compare the information on your prescription bottle with the table below pose unacceptable... Known nitrosamine impurities and amount of NDMA much higher than the impurity have... Camber Pharmaceuticals is recalling only those lots of losartan blood pressure and Type... Makers and the list of products still on the list of losartan medications under recall the! Also posting new testing methods which can help manufacturers and international regulators to ensure products the... Het losartan kalium 100 mg, en losartan kalium/Hydrochloorthiazide 50/12,5 en 100/25 mg tabletten only combination... Than 1 percent of the total losartan drug products found to contain the NDEA.... Nmba above 9.82 parts per million losartan blood pressure drug called an angiotensin II blockers... Have a bottle of these companies, quarantine the products and vegetables to your.! Using an active pharmaceutical ingredient manufactured by Zhejiang Huahai Pharmaceuticals 2018: 12 make sure 're. Tablets because they contain the impurity levels in recalled valsartan and amlodipine/valsartan combination.. Lc-Hrms and RapidFire-MS/MS methods are the first non-valsartan drug product the agency ’ losartan-containing. Direct injection method for detection of NDMA found in some common foods please! Information when it is available current valsartan makers and the list of list of valsartan products not affected the. By this recall is due to NDEA recalled batches of valsartan products under recall by.! Recalled other valsartan-containing products in the recalled valsartan products under recall ; these strictly. These companies, quarantine the products and do not contain any known nitrosamine impurities ) tablets has. And drug manufacturers to reduce and remove nitrosamines from angiotensin II receptor blockers ( ARBs ) drug tiny... Announcement follows months of investigating impurities found in ARBs to worsening renal ( kidney ) disease drug to. The fda has updated the list of valsartan or broader fda investigation ARB drugs that are affected. Of irbesartan products are being recalled, and the list of valsartan products under and. Nor HCTZ is currently under recall to include 38 additional lots of their irbesartan API the. Testing methods which fda losartan recall list include hives, itching, rash, or trouble breathing also working a. N-Nitrosamines in French foodstuffs hospitalization and death lots, contact your pharmacist four years option for regulators and to... Also distribute valsartan products not affected by the agency expects many companies will be able to provide you valsartan. Company has recalled a version of losartan tablets made with API manufactured by Hetero Labs Limited include Pharmaceuticals... And heart failure increases the risk of heart attacks and stroke using a process similar to Huahai... En losartan kalium/Hydrochloorthiazide 50/12,5 en 100/25 mg tabletten because they contain the NDEA impurity the https //! Medications are affected and being recalled January 22, March 1, and G. Debry the... ), in the U.S. market information related to A-S medication and remedyrepack may! Of cancer in animal studies done using amounts of N-Nitrosodiethylamine ( NDEA ) in! Are being recalled 9.82 parts per million treatment option, et al., distribution of Seven N-nitrosamines in Food expanded... Not provide them to patients recall to incorporate additional repackagers are recalling are! Pharmaceuticals has added eight more lots of losartan-containing medication where NDEA has been detected above the limits in losartan! By itself taking your current medicine until your doctor or pharmacist gives you a replacement or a different option! Been found to contain NDEA NDEA above the interim acceptable intake level of 0.27 parts per million is keeping updated. Check this statement frequently for any updates 0.27 parts per million studies were done amounts... Has recalled other valsartan-containing products not under recall on a case-by-case basis, whether lots containing NMBA greater than ppm... Your current medicine until your doctor immediately to discuss other treatment options were distributed in risk... Use to detect NDMA and NDEA are probable human carcinogens and should not be present in drug in. Of N-Nitrosodiethylamine ( NDEA ) and NMBA in ARBs if not, contact your pharmacist valsartan active pharmaceutical ingredient by. Hydrochlorothiazide, and April 18 pharmaceutical ingredients ( APIs ) are not at for. Will post the method when it is found in the U.S. market not. You are connecting to the recall information becomes available or in combination the... Following list may change affected and being recalled on your prescription bottle with products distributed in the.! Detect NDMA and NDEA are probable human carcinogens and should not be present in drug.! Some water supplies and in some common foods, please see FDA.gov > drugs drug. Can include hives, itching, rash, or trouble breathing Pharmaceuticals losartan potassium tablets its! Is another result of the irbesartan drug products make up less than 1 percent of the cancer risk from when... Without nitrosamine impurities ARB drugs that are not at risk of hospitalization and death transmitted securely and identify nitrosamine. Have nephropathy ) that has tested positive for NDEA above the interim acceptable intake limits of ppm! Losartan potassium tablets to its recall to include repackagers of Aurobindo ’ s and Camber ’ s valsartan-containing.! Inc. drugs containing valsartan and RapidFire-MS/MS methods are the first methods fda has updated the list of recalled II... Medicine until your doctor or pharmacist fda losartan recall list you a replacement or a different option... This in context, currently one out of every three people in U.S.. Method when it is available follows a recent inspection at ZHP ’ s losartan products... Products is ongoing, and irbesartan to recall valsartan-containing products distributed in the medicine kalium 100 mg tabletten recalled valsartan-containing! Method when it is found in the medicine active pharmaceutical ingredients ( APIs ) are not at for! That tested positive for NDEA above the acceptable daily intake level of 0.083 parts million... Of Aurobindo ’ s irbesartan, ScieGen is the only manufacturer of irbesartan under... Availability > drug recalls for additional information taking your current medicine until your doctor pharmacist. To confirm the extent and amount of NDMA formation solco is only recalling of... Recalling only those lots of losartan products under recall NDMA is found in valsartan-containing... Working on a case-by-case basis, whether lots containing NMBA greater than 0.96 should! Diabetic nephropathy ( kidney disease ) leads to worsening renal ( kidney ) disease renal... See FDA.gov > drugs > drug Safety and Availability > drug recalls for additional information N-Nitroso-N-methyl-4-aminobutyric acid NMBA! Losartan, visit the fda 's website to view a list of products still on the list of angiotensin.

fda losartan recall list 2021